Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Capital Expenditures (2016 - 2025)

LivaNova's Capital Expenditures history spans 11 years, with the latest figure at $32.2 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 209.75% year-over-year to $32.2 million; the TTM value through Dec 2025 reached $81.0 million, up 72.06%, while the annual FY2025 figure was $81.0 million, 72.06% up from the prior year.
  • Capital Expenditures for Q4 2025 was $32.2 million at LivaNova, up from $22.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $32.2 million in Q4 2025 and bottomed at $3.3 million in Q3 2021.
  • The 5-year median for Capital Expenditures is $8.5 million (2021), against an average of $10.8 million.
  • The largest annual shift saw Capital Expenditures tumbled 68.82% in 2021 before it surged 209.75% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $7.6 million in 2021, then increased by 20.42% to $9.1 million in 2022, then surged by 41.44% to $12.9 million in 2023, then dropped by 19.45% to $10.4 million in 2024, then soared by 209.75% to $32.2 million in 2025.
  • Per Business Quant, the three most recent readings for LIVN's Capital Expenditures are $32.2 million (Q4 2025), $22.9 million (Q3 2025), and $15.1 million (Q2 2025).